Canton Hathaway’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.2K Hold
450
0.01% 237
2026
Q1
$39K Buy
450
+65
+17% +$6.23K 0.01% 217
2025
Q4
$37K Sell
385
-11
-3% -$1.07K 0.01% 227
2025
Q3
$38K Hold
396
0.01% 226
2025
Q2
$35K Buy
396
+46
+13% +$3.9K 0.01% 224
2025
Q1
$31K Buy
350
+68
+24% +$6.08K 0.01% 233
2024
Q4
$23K Buy
+282
New +$24.4K 0.01% 235
2023
Q4
Sell
-3,112
Closed -$244K 248
2023
Q3
$244K Hold
3,112
0.08% 83
2023
Q2
$274K Hold
3,112
0.09% 79
2023
Q1
$251K Hold
3,112
0.09% 80
2022
Q4
$242K Hold
3,112
0.08% 83
2022
Q3
$251K Hold
3,112
0.09% 83
2022
Q2
$279K Sell
3,112
-23,788
-88% -$2.41M 0.1% 83
2022
Q1
$2.98M Sell
26,900
-450
-2% -$47.5K 0.84% 18
2021
Q4
$2.83M Buy
27,350
+10
+0% +$1.16K 0.77% 24
2021
Q3
$3.43M Buy
27,340
+432
+2% +$55.9K 0.98% 18
2021
Q2
$3.34M Buy
26,908
+158
+0.6% +$19.8K 0.98% 17
2021
Q1
$3.16M Buy
26,750
+993
+4% +$116K 1.01% 17
2020
Q4
$3.02M Buy
25,757
+137
+0.5% +$15.1K 1.02% 15
2020
Q3
$2.66M Buy
25,620
+11,787
+85% +$1.18M 1.09% 12
2020
Q2
$1.27M Buy
13,833
+736
+6% +$70.6K 0.83% 14
2020
Q1
$1.18M Sell
13,097
-1,376
-10% -$146K 0.84% 13
2019
Q4
$1.64M Hold
14,473
0.84% 15
2019
Q3
$1.57M Buy
14,473
+219
+2% +$22.8K 0.87% 15
2019
Q2
$1.39M Buy
14,254
+100
+0.7% +$9.13K 0.78% 14
2019
Q1
$1.29M Buy
14,154
+2,864
+25% +$256K 0.75% 16
2018
Q4
$1.03M Buy
11,290
+5,560
+97% +$520K 0.66% 15
2018
Q3
$564K Buy
+5,730
New +$530K 0.35% 29

Other funds holding MDT

Canton Hathaway's MDT Position: Q2 2026 in Review

Canton Hathaway held its Medtronic (MDT) position steady in Q2 2026 at 450 shares worth $35.2K. The position accounts for 0.01% of the portfolio, ranked #237.

Canton Hathaway first reported a position in MDT in Q3 2018 and has held it in 28 quarters since. The position peaked at $3.43M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Canton Hathaway held 450 shares of Medtronic worth $35.2K as of Q2 2026.
  • Canton Hathaway left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.01% of Canton Hathaway's portfolio in Q2 2026, its #237 holding.
  • Canton Hathaway first reported a position in Medtronic in Q3 2018 and has held it in 28 quarters since.
  • Canton Hathaway's Medtronic position peaked at $3.43M in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.